Holy Basil (Tulsi)
Ocimum sanctum · Tulsi · The Queen of Herbs
Evidence grade 2 of 5, Thin. Read how the Atlas grades evidence.
The evidence sits at preliminary-to-early-mixed. The anchoring source is the Jamshidi and Cohen 2017 systematic review in Evidence-Based Complementary and Alternative Medicine, which pooled 24 human studies (1,111 participants) but rated only three as high quality by Jadad score, with the rest scoring 0 to 3, most trials small and short (2 to 13 weeks). Signals for stress, mood, glycemic control, and lipids ran in a favorable direction but rested on methodologically weak trials. The strongest single line is metabolic: a 2018 meta-analysis of randomized trials (Devra and colleagues, Clinical Nutrition ESPEN) found a pooled fasting glucose reduction of about 15.7 mg/dL, though with very high heterogeneity (I-squared over 91 percent) and driven by small studies. A 2 reflects a real, reproducible metabolic signal held back by weak methodology, plus preliminary stress trials that have not been replicated at scale.
- FDA
- Legal supplement (DSHEA); GRAS food ingredient
- WADA
- Not prohibited
Reference only. Not medical advice.
What can go wrong
Well-tolerated at studied doses, but real cautions in pregnancy and fertility, with thyroid, bleeding, and blood-sugar interactions and variable extract quality.
Holy basil, known across India as Tulsi and revered for millennia as an earthly form of the goddess Tulasi, is among the most culturally embedded medicinal plants of any tradition. Ayurveda classifies it as a rasayana, a rejuvenating tonic, and modern chemistry has characterized eugenol, ursolic acid, rosmarinic acid, and the ocimumosides as its notable constituents. The honest headline is a modest one: the 2017 Jamshidi and Cohen systematic review found favorable but methodologically weak human evidence for stress, glycemic, and lipid effects, with only three of 24 studies rated high quality. A 2018 meta-analysis adds a reproducible fasting-glucose signal in metabolic disease, though the trials were small and heterogeneous. The plant carries real cautions around pregnancy, fertility, thyroid, and bleeding that its gentle reputation tends to obscure.
Three thousand years of Ayurvedic veneration meets modest modern stress evidence.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
How it is supposed to work
Holy basil (Ocimum sanctum, also classified as Ocimum tenuiflorum), known in Sanskrit as Tulsi (the "incomparable one") and in Hindu tradition as "the Queen of Herbs", has been cultivated and venerated in India for more than three thousand years. The plant occupies a unique position in Hindu religious practice, planted in household courtyards across the subcontinent and worshipped as the earthly manifestation of the goddess Tulsi. This cultural and religious embeddedness has preserved its medicinal use across millennia in a way few other medicinal plants have achieved. Three primary cultivars are recognized in Indian tradition: Rama Tulsi (green leaves, milder flavor), Krishna Tulsi (purple-tinged leaves, stronger flavor, often considered most potent for medicinal use), and Vana Tulsi (wild forest variant, distinct chemistry). Modern clinical research has focused primarily on Rama and Krishna varieties or hybrid extracts. The active compound profile is unusually diverse. Eugenol (a phenylpropanoid also found in clove oil, where it dominates) is the predominant volatile oil constituent and contributes to the characteristic clove-like aromatic profile. Ursolic acid (a pentacyclic triterpenoid) provides anti-inflammatory and metabolic effects. Ocimumosides A and B are specific glycosides characterized in modern research as contributing to stress modulation effects. Rosmarinic acid (a polyphenolic compound shared with rosemary, sage, and other Lamiaceae family members) provides antioxidant activity. Additional compounds (apigenin, luteolin, β-caryophyllene, methyl eugenol) contribute to the complex pharmacology. The mechanism of stress modulation involves multiple pathways: HPA axis modulation reducing cortisol response (the basis of the Saxena 2012 stress trial findings), anti-inflammatory effects through NF-kB pathway modulation, mild anxiolytic effects through possible GABAergic activity, and modest glycemic effects through pancreatic beta-cell support and insulin sensitivity improvements. The Saxena 2012 and Bhattacharya series provide the strongest modern stress evidence; the glycemic evidence (Agrawal 1996 and subsequent) supports modest type 2 diabetes adjunctive use. Effect sizes across these applications are modest compared to pharmaceutical alternatives but the safety profile and cultural inheritance make Tulsi reasonable in functional medicine and Ayurvedic-integrated practice. The plant retains stronger evidence base than its commercial scale would suggest, much Tulsi research is published in Indian journals that receive limited Western citation despite methodological adequacy.
How it is taken
Modern Tulsi dosing follows the modest standardized extract paradigm or the more traditional whole-leaf approach. For stress and adaptogenic applications, 300-1200mg/day of standardized extract (typically 2.5% ursolic acid standardization) divided into 2-3 doses provides the modern clinical evidence-supported range. The Saxena 2012 stress trial used 1200mg daily; Sampath 2015 cognitive trial used 600mg daily. For type 2 diabetes adjunctive use, 1-2.5g daily Tulsi leaf powder follows the Agrawal 1996 and Singh 2014 protocols. Take with or without food; absorption is acceptable either way. Traditional preparation (fresh leaves chewed, tea brewed from fresh or dried leaves, leaf powder mixed with water or honey) remains widely used in Indian household practice and supports the cultural-medical integration. For traditional preparations: 2-4 cups Tulsi tea daily, 5-10 fresh leaves daily chewed, or 2-5g leaf powder daily. Effects on stress and cognitive endpoints develop over 2-6 weeks of consistent use; acute effects after single doses are modest. The pregnancy contraindication is critical, Tulsi traditional emmenagogue and theoretical uterine stimulant effects make it inappropriate during pregnancy and attempts to conceive. The glucose-lowering effect can compound with diabetes medications and warrants blood glucose monitoring when initiating in users on established diabetes treatment. Quality matters substantially, adulteration with other Ocimum species (Ocimum basilicum / sweet basil, Ocimum americanum) and standardization variability across commercial products produce inconsistent clinical outcomes.
- Standardized extract (stress)
- 300-1200mg/day for 6+ weeks
- Standardized extract (cognitive)
- 600mg/day
- Leaf powder (diabetes)
- 1-2.5g/day
- Fresh leaves (traditional)
- 5-10 leaves daily chewed
- Tea (traditional)
- 2-4 cups daily
- Standardization target
- 2.5% ursolic acid
- Time to acute effect
- Modest within hours
- Time to chronic adaptation
- 2-6 weeks for stress; 30-60 days for glycemic
Which form to buy
Not all preparations of the same ingredient are the same thing, and the trials were run on particular ones.
Tulsi Leaf Powder (Traditional)
Whole-leaf powder is the traditional Ayurvedic form, used in classical formulas and modern Indian practice. Quality and active compound content varies based on harvest, drying, and storage. Cost-effective; provides full plant compound matrix. Krishna variety often considered most potent medicinally.
Tulsi Standardized Extract (2.5% Ursolic Acid)
Standardized extract concentrated to typically 2.5% ursolic acid (commercial standardization target). Used in most modern clinical trials including Saxena 2012 and Sampath 2015. Substantially more potent than leaf powder per gram; convenient dosing. Brands include Himalaya (Hindi tradition with significant scientific publication record), Banyan Botanicals, Organic India, and others.
Tulsi Tea (Fresh or Dried Leaves)
Among the most popular traditional preparations, Tulsi tea is consumed daily in many Indian households. Pleasant clove-like aromatic profile; supports the cultural inheritance and traditional daily-use pattern. Active compound content modest per cup; multiple cups daily provide therapeutic accumulation.
Fresh Tulsi Leaves (Direct Chewing)
The most traditional preparation, fresh leaves chewed daily in Hindu morning practice. Active compound content depends on plant variety, growing conditions, and seasonal factors. Cultural and spiritual integration is unique to fresh leaf consumption.
Tulsi Tincture / Liquid Extract
Alcoholic tinctures (typically 1:5 ratio) provide flexible dosing. Quality varies across products; verify ocimumoside or ursolic acid standardization for therapeutic use. Common in Western herbal practice.
Multi-Adaptogen Blends with Tulsi
Tulsi appears in many "stress," "adaptogen," and Ayurvedic-positioned blends alongside ashwagandha, brahmi, shatavari, and other herbs. Dose disclosure varies; therapeutic Tulsi dose (300-1200mg standardized extract) often not achieved in blended products. Verify individual Tulsi content.
Tulsi Essential Oil (Topical/Aromatherapy)
Essential oil from Tulsi leaves, different application context than oral supplementation. Used in aromatherapy and topical applications. NOT for oral consumption at essential oil concentrations (would be toxic). Eugenol-rich profile makes essential oil distinct preparation entirely.
Krishna Tulsi (Purple Variety) Products
Krishna variety often considered most potent medicinally in classical Ayurvedic tradition. Some commercial products specifically use Krishna variety; comparative clinical evidence is limited. Reasonable preference for users seeking traditional Ayurvedic alignment.
Who it works for, and who it does not
Stress and stress-related symptoms
The strongest modern indication. Saxena 2012 RCT: 1200mg daily for 6 weeks produced clinically meaningful improvements in stress symptoms (forgetfulness, sleep, exhaustion, sexual problems) versus placebo. Reasonable component of stress management protocols, particularly in users seeking botanical or culturally-aligned approaches.
Type 2 diabetes (glycemic adjunct)
Agrawal 1996, Singh 2014, and subsequent work support modest glycemic effects, typically 5-15% reduction in fasting glucose and HbA1c. Effect sizes substantially smaller than metformin or other established diabetes pharmaceuticals; reasonable as adjunct with appropriate monitoring. Coordinate with treating clinician for combination with diabetes medications.
Anxiety symptoms (mild to moderate)
Bhattacharya series and Saxena 2012 support modest anxiety reduction. Effect sizes smaller than established anxiolytics; reasonable for users preferring botanical approach in mild anxiety. Not substitute for established treatment in moderate-to-severe anxiety disorders.
Cognitive function and memory
Sampath 2015 supports modest attention and short-term memory benefits. Effect sizes modest; reasonable component of cognitive support protocols but not transformative. Coordinate with neurology/psychiatry for established cognitive disorders.
Healthy adults seeking daily wellness
The most common traditional Indian use case. 2-4 cups Tulsi tea daily or modest standardized extract supplementation supports overall wellness in the Ayurvedic tradition. Effect sizes modest at standard doses; cultural and spiritual integration is part of the value proposition for many users.
Inflammation and oxidative stress
Anti-inflammatory and antioxidant properties demonstrated in mechanistic studies; clinical applications in specific inflammatory conditions are preliminary. Reasonable component of comprehensive anti-inflammatory protocols.
Pregnancy and lactation
CRITICAL: Avoid during pregnancy and attempts to conceive. Traditional emmenagogue (menstruation-promoting) properties and theoretical uterine stimulant effects (eugenol-mediated) warrant caution. Some animal studies suggest possible reproductive effects. The pregnancy contraindication is established in most traditional and modern Ayurvedic practice guidelines.
Active hypoglycemia or diabetes on medications
Modest glucose-lowering effect can compound with diabetes medications producing hypoglycemia. Monitor blood glucose closely when adding Tulsi to established diabetes treatment; coordinate with treating physician.
Anticoagulant users
Eugenol has antiplatelet activity at higher doses. Theoretical additive bleeding risk with anticoagulant therapy. Coordinate with prescribing physician.
Taken with other things
Combinations people actually use. Evidence for one ingredient is not evidence for a pair.
Ashwagandha
Common Ayurvedic adaptogen pairing. Mechanistically complementary, Tulsi has mild stimulant character and metabolic effects; ashwagandha is more sedating with chronic-only HPA axis effects. The combination is traditional in Ayurveda and addresses multiple stress dimensions.
Turmeric (Curcumin)
Common Ayurvedic combination. Both have anti-inflammatory mechanisms through distinct pathways; reasonable comprehensive anti-inflammatory and adaptogenic combination.
Brahmi (Bacopa monnieri)
Traditional Ayurvedic cognitive-supportive combination. Both have modest cognitive enhancement evidence; mechanistically complementary. Reasonable in cognitive support protocols.
Diabetes Medications
Tulsi has modest glucose-lowering effect that can compound with metformin, sulfonylureas, insulin, and other diabetes medications. Monitor blood glucose closely when initiating; endocrinology coordination reasonable.
Anticoagulants and Antiplatelet Drugs
Eugenol has antiplatelet activity at higher doses. Theoretical additive bleeding risk with warfarin, DOACs, aspirin. Coordinate with prescribing physician; monitor for bleeding signs.
Pregnancy
CRITICAL CONTRAINDICATION. Traditional emmenagogue properties and theoretical uterine stimulant effects warrant avoidance during pregnancy and attempts to conceive. Established in Ayurvedic and modern practice guidelines.
Thyroid Medications
Some preliminary evidence suggests Tulsi may modulate thyroid function. Limited clinical relevance at typical supplementation doses; coordinate with prescribing physician in users with established thyroid disease on replacement therapy.
Sedatives and CNS Depressants
Mild anxiolytic activity may produce additive sedation with established sedatives. Modest concern at typical doses; coordinate with prescribing physician.
Pre-Surgery Period
Antiplatelet activity at higher doses warrants 1-2 week discontinuation before elective surgery as conservative practice.
What to look for on the label
Look for: explicit species specification (Ocimum sanctum or Ocimum tenuiflorum); ursolic acid standardization (2.5% target) for extract products; variety specification (Krishna or Rama) for traditional alignment if pursued; certified organic source given India's agricultural context; heavy metal and pesticide testing disclosure; reasonable price (premium for branded Organic India and Himalaya products reflects supply chain quality; very high pricing without specific differentiation suspect). Avoid: products labeled simply "basil" or "holy basil" without Ocimum species specification; products without standardization disclosure; products from manufacturers without third-party testing; pregnancy use entirely; products marketed for pregnancy "stress" or "fertility" applications (pregnancy contraindication is established).
Safety in detail
- Generally well-tolerated at studied doses. No documented serious adverse events at standard supplementation doses across multiple clinical trials.
- PREGNANCY CONTRAINDICATION is critical, traditional emmenagogue and theoretical uterine stimulant effects (eugenol-mediated) warrant avoidance during pregnancy and attempts to conceive. Established in both Ayurvedic and modern practice guidelines.
- Lactation: limited systematic safety data; generally avoid without specialist guidance.
- Glucose-lowering effect can produce hypoglycemia in users on diabetes medications. Monitor blood glucose when initiating; coordinate with endocrinology.
- Mild antiplatelet activity at higher doses through eugenol. Theoretical bleeding risk with anticoagulants; pre-surgical discontinuation 1-2 weeks before elective procedures.
- Mild GI upset (nausea, mild stomach discomfort) at high doses; managed by dividing or taking with food.
- Eugenol contact dermatitis possible with topical applications; not typically problematic with oral supplementation.
- Possible mild thyroid function modulation, limited clinical relevance but worth noting for users with thyroid disease on replacement.
- Pediatric use: limited systematic safety data outside traditional Indian household practice. Specialist coordination for therapeutic doses.
- Long-term safety record across thousands of years of Indian household use is substantial; modern clinical trials confirm acceptable safety at standardized doses.
What people get wrong
Often saidTulsi is the same as sweet basil (Ocimum basilicum).
ActuallyIt is not. Tulsi is Ocimum sanctum (also classified as Ocimum tenuiflorum), a different species with distinct active compound profile and traditional medicinal use. Sweet basil is culinary; Tulsi is medicinal. Species verification matters for therapeutic use.
Often saidTulsi works dramatically for severe stress and anxiety.
ActuallyModest effect sizes are the realistic expectation. Saxena 2012 showed clinically meaningful but modest improvements in stress symptoms over 6 weeks. Not substitute for established treatment in severe stress or clinically significant anxiety disorders.
Often saidTulsi is safe for pregnancy because it's a traditional Indian herb.
ActuallyCritical contraindication. Traditional Ayurvedic practice ALSO contraindicates Tulsi in pregnancy (it is a traditional emmenagogue). Theoretical uterine stimulant effects via eugenol. Both traditional and modern guidance avoids Tulsi in pregnancy and attempts to conceive.
Often saidKrishna Tulsi (purple) is dramatically more effective than Rama (green).
ActuallyTraditional preference for Krishna is consistent but comparative clinical evidence is limited. Both varieties contain the same primary active compounds at variable concentrations. Most modern clinical trials use either variety or hybrid extracts.
Often saidHigher Tulsi doses always produce better results.
ActuallyMost clinical evidence clusters at 300-1200mg/day standardized extract. Higher doses produce diminishing returns and increased GI sensitivity. The therapeutic window is real.
Often saidTulsi can replace diabetes medications.
ActuallyIt cannot. Modest glycemic effects (5-15% reduction) are substantially smaller than established diabetes pharmaceuticals. Reasonable adjunct with monitoring; not substitute for established diabetes care.
Often saidYou only need to drink Tulsi tea occasionally for benefits.
ActuallyTherapeutic effects require consistent use, 2-4 cups daily traditional preparation, or 300-1200mg standardized extract daily for 6+ weeks. Occasional tea consumption is pleasant but unlikely to produce clinical effects.
Who profits, and who pushes back
Conservative Western evidence assessment
Much Tulsi research is published in Indian journals with limited Western citation indexing. Methodological standards vary; some studies meet rigorous Western RCT criteria, others do not. The "substantial clinical evidence" framing should engage with the journal-quality stratification that distinguishes high-quality methodologically rigorous trials (Saxena 2012, Sampath 2015, Cohen reviews) from less rigorous publications. Modest effect sizes versus pharmaceutical alternatives in stress, diabetes, and cognition applications should be communicated clearly.
Mainstream endocrinology
Despite modest glycemic effects in Tulsi diabetes trials (5-15% reduction in fasting glucose and HbA1c), mainstream endocrinology has not incorporated Tulsi into standard diabetes treatment guidelines. Effect sizes substantially smaller than metformin, GLP-1 agonists, SGLT-2 inhibitors, and other established diabetes medications. Reasonable as adjunct with appropriate monitoring; not substitute for established diabetes care.
Marc Cohen
Leading Western academic Tulsi researcher; authored comprehensive 2014 review and subsequent systematic reviews. Independent academic; brought substantial Western methodology to Tulsi research.
Salil Bhattacharya
Foundational Indian researcher whose series through 1980s-2000s built the modern stress-modulation evidence base. Independent academic.
Organic India
Sells this. Has a commercial interest in a product sold as this compound, as of July 2026.
Founded 1997 with substantial Tulsi product line and vertical farm-to-product integration. Major commercial advocate; disclosed industry source. Has supported substantial Tulsi research investment.
Himalaya Wellness
Sells this. Has a commercial interest in a product sold as this compound, as of July 2026.
Long Indian heritage with substantial Tulsi product line and clinical research investment. Major commercial advocate; disclosed industry source. Significant scientific publication record.
Ayurvedic medical community
Long-established Ayurvedic clinical use of Tulsi for stress, metabolic, immune, and adaptogenic applications. Substantial practical inheritance with diverse practice patterns.
Indian household practice
Among the most successful religious-medical integration in continuous practice. Tulsi cultivation in household courtyards across India represents extraordinary cultural-medical inheritance distinct from typical commercial supplement contexts.
Where the research comes from
Most of the published research on this comes from one place. 58% of it is from India. Findings that no unrelated group has reproduced are weaker than the study count makes them look.
| Place | Share of published research |
|---|---|
| India | 58% |
| North America | 18% |
| Europe | 12% |
| Other | 12% |
Research published from: India.
How we got here
Tulsi's history in human medicine and religious practice is among the longest of any plant globally, extending more than three thousand years in continuous documented use. Vedic literature (1500-500 BCE) references Tulsi extensively; the Charaka Samhita and Sushruta Samhita (foundational Ayurvedic medical texts ~500 BCE to 500 CE) establish Tulsi's position as primary adaptogen and rasayana (rejuvenative) herb. The Padma Purana and other Puranic texts establish the religious veneration of Tulsi as the earthly manifestation of the goddess Tulsi, wife of Vishnu. The Tulsi Vivah ceremony (celebrated annually across India) marks Tulsi's marriage to Vishnu/Krishna and represents one of the most widely observed religious-medical integration ceremonies in any culture. The practical household integration is exceptional. Across the Indian subcontinent for centuries, Hindu households have maintained Tulsi plants in dedicated courtyard shrines (often called Tulsi Vrindavan or Tulsi Manjari). Morning prayers traditionally involve Tulsi worship; fresh leaves are chewed daily; Tulsi tea is consumed routinely; leaf powder appears in diverse medicinal preparations. This pattern represents perhaps the most successful religious-medical integration in continuous practice in any culture, a context that has preserved Tulsi's medicinal use through colonialism, modernization, and globalization. The modern scientific era began in the 1950s-70s with Indian biomedical research characterizing active compounds and pharmacology. The substantial Bhattacharya series at Banaras Hindu University through the 1980s-2000s built the modern stress-modulation evidence base. Agrawal 1996 established the type 2 diabetes glycemic case. The Saxena 2012 Evidence-Based Complementary and Alternative Medicine trial provided the methodologically rigorous modern stress evidence. Marc Cohen's reviews and research at RMIT University Australia (Cohen 2014 and subsequent) brought substantial Western academic engagement with Tulsi. The consumer market era has grown substantially since the 1990s-2000s, particularly through Indian heritage brands (Organic India founded 1997 with substantial Tulsi product line; Himalaya Wellness with long Indian heritage) and Western functional medicine adoption. The growth has been notable but Tulsi has remained a smaller commercial category than ashwagandha despite arguably equivalent traditional and modern evidence base, partly reflecting ashwagandha's more accessible cultural framing and partly reflecting Tulsi's religious associations that may complicate Western secular positioning. The pregnancy contraindication has emerged consistently from both traditional Ayurvedic practice and modern safety research. The eugenol-mediated theoretical uterine stimulant effects and traditional emmenagogue use establish the contraindication firmly in both evidence bases. Quality challenges have been substantial. Ocimum basilicum (sweet basil) and other Ocimum species are sometimes commercially substituted for Ocimum sanctum without consumer awareness. India's agricultural landscape produces variable pesticide and heavy metal contamination requiring quality verification. The 2014-2016 American Botanical Council Botanical Adulterants Prevention Program addressed some of these concerns. The modern integration of Tulsi into mainstream wellness, yoga-adjacent culture, and functional medicine has produced substantial growth without fully achieving the commercial scale of ashwagandha. The religious-medical integration that distinguishes Tulsi remains a complex framing challenge for secular Western markets, many users appreciate the cultural depth while others prefer the more secular ashwagandha alternative for similar stress applications.
- ~1500 BCEVedic literature references Tulsi extensively
- ~500 BCE-500 CECharaka and Sushruta Samhitas establish medicinal use
- Centuries continuingHindu household courtyard cultivation across India
- 1950s-70sIndian biomedical research characterizes active compounds
- 1980s-2000sBhattacharya series at Banaras Hindu University
- 1996Agrawal type 2 diabetes glycemic trial
- 1997Organic India founded with substantial Tulsi product line
- 2005Mohan radioprotection preclinical evidence
- 2012Saxena modern stress trial (methodologically rigorous)
- 2014Cohen comprehensive review consolidates modern evidence
- 2014Singh Krishna Tulsi diabetes trial
- 2015Sampath cognitive function trial
- 2017Jamshidi and Cohen systematic review
What we do not know
- Whether the substantial Indian clinical research base (much published in Indian journals with limited Western citation) achieves methodological standards equivalent to Western RCTs in equivalent clinical contexts.
- Optimal standardization parameters, current 2.5% ursolic acid is convention but other compound markers (ocimumosides, eugenol content, rosmarinic acid) may better predict clinical outcomes.
- Whether Krishna Tulsi (purple variety) produces clinically distinguishable outcomes versus Rama Tulsi (green variety), traditional Ayurvedic preference for Krishna is consistent but comparative clinical evidence is limited.
- Whether the religious-medical integration produces measurable adherence and outcome benefits versus pharmacologically equivalent extract supplementation, research at this intersection is limited.
- Whether Tulsi has applications in cardiovascular protection or chronic inflammatory conditions beyond the established stress and metabolic indications.
- How best to address the species adulteration market issue, Ocimum basilicum (sweet basil) and other Ocimum species may be commercially substituted; third-party species verification needs.
- Whether the pregnancy contraindication should be relaxed for specific contexts (postpartum mood support, lactation support), current guidance is broad avoidance but specific safety research is limited.
- Whether commercial Tulsi cultivation can scale to meet rising Western demand while maintaining quality and supporting traditional Indian household-cultivation tradition.
Legal status
Universally available globally as dietary supplement, fresh herb (in Indian groceries), and tea. Legal under DSHEA in the United States and equivalent supplement regulations globally. GRAS status as food ingredient in many jurisdictions. Not on WADA prohibited list. Major retail brands include Organic India (Indian heritage brand with substantial Tulsi product line), Himalaya (also Indian heritage), Banyan Botanicals, Gaia Herbs, Pukka Herbs, Yogi Tea (Tulsi tea blends), and many functional medicine and Ayurvedic-positioned brands. Fresh Tulsi is widely available in Indian grocery stores in many Western cities. Indian production is concentrated in commercial farms in Madhya Pradesh, Uttar Pradesh, and other states; certified organic and sustainable cultivation programs are widespread given the religious significance of the plant. Quality variation across brands is substantial, verify standardization (ursolic acid content) for clinical-grade use. The cultural and religious context creates an unusual supply chain stability, Tulsi is grown extensively in household courtyards across India as well as commercially.
Status current as of July 2026. Regulatory positions change, sometimes quickly.
The market for this
What follows describes how this is bought and sold. It is not a buying guide and it is not an endorsement of any seller.
Tulsi production is concentrated in India (Uttar Pradesh, Madhya Pradesh, Maharashtra, and other states) with substantial certified organic and sustainable cultivation programs. Religious significance has driven exceptional supply chain integration, Tulsi is grown extensively in household courtyards across India in addition to commercial farms, providing genuine traditional sourcing that few medicinal plants achieve at scale. Quality concerns center on species verification (other Ocimum species can be commercially substituted), standardization variability, and pesticide/heavy metal contamination (India's agricultural landscape produces variable quality control). Organic India and Himalaya have substantial vertical integration from farm to product, supporting quality verification. Standardization to ursolic acid (typical 2.5% target) is common but other compound markers may be more clinically relevant. Third-party testing for species identity, active compound standardization, heavy metals, and pesticides provides quality verification for clinical-grade use. NSF, USP, and Informed Choice third-party programs include Tulsi product verification.
At a glance
- Species
- Ocimum sanctum (also classified Ocimum tenuiflorum)
- Sanskrit name
- Tulsi ("the incomparable one")
- Traditional title
- Queen of Herbs (Hindu tradition)
- Cultivars
- Rama (green), Krishna (purple), Vana (wild)
- Active compounds
- Eugenol, ursolic acid, ocimumosides A/B, rosmarinic acid
- Standardization target
- 2.5% ursolic acid
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Holy Basil (Tulsi). A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
2017 systematic review of 24 human studies, only 3 high-quality, favorable but weak evidence for stress/glycemic/lipid effects
Jamshidi & Cohen, Evidence-Based Complementary and Alternative Medicine (PMC)
Same systematic review, publisher version with study counts, Jadad quality ratings, dose ranges, and safety tally
Meta-analysis of RCTs: Tulsi lowers fasting glucose (~-15.7 mg/dL) and improves lipids in metabolic disease, high heterogeneity, tolerated to ~2.5 g/day
Constituents, evidence quality, thyroid/bleeding/pregnancy cautions and drug interactions (anticoagulant, antidiabetic, barbiturate, thyroid)
RCT of Holixer Ocimum tenuiflorum extract on stress, mood, and sleep in stressed adults
Consumer safety guidance: pregnancy/conception caution, antiplatelet and blood-glucose interactions, up-to-8-week safety window
Reproductive-system effects of Ocimum sanctum including antifertility and antispermatogenic findings in animal models
Effects of Ocimum sanctum on the reproductive system: an updated review (ResearchGate)
Ethnobotany, Ayurvedic rasayana status, and therapeutic overview of Ocimum sanctum
Ocimum sanctum Linn.: a reservoir plant for therapeutic applications (PMC)
Religious history: Tulasi as manifestation of a goddess, link to Vishnu/Krishna, courtyard worship in Hindu households
Phytochemistry and molecular pharmacology of Ocimum sanctum constituents and proposed mechanisms
Comprehensive review on phytochemistry and pharmacology of Ocimum sanctum (ScienceDirect)
The studies that matter
Ayurvedic classical texts~1500 BCE-500 CE
Charaka Samhita and Sushruta Samhita, foundational Ayurvedic medical texts, establish Tulsi's position as primary adaptogen and rasayana ("rejuvenative") herb. Foundational classical evidence base spanning thousands of years.
Agrawal type 2 diabetes trialJ Clin Pharmacol Ther 1996
Indian RCT in type 2 diabetes patients: 2.5g Tulsi leaf powder daily for 30 days reduced fasting blood glucose (~17% reduction) and post-meal glucose (~7% reduction) versus placebo. Foundational glycemic evidence at modest effect sizes.
Bhattacharya stress and anxiety researchIndian J Exp Biol 2000s
Series of preclinical and clinical studies by Salil Bhattacharya and colleagues at Banaras Hindu University establishing the stress-modulation evidence base. Foundational mechanistic and clinical work for adaptogen positioning.
Saxena stress trialEvid Based Complement Alternat Med 2012
Indian RCT: 1200mg Tulsi extract daily for 6 weeks produced clinically meaningful improvements in stress-related symptoms (forgetfulness, sexual problems, exhaustion, sleep problems) versus placebo. Foundational modern stress evidence at higher effect sizes than typically achieved by other adaptogens in similar populations.
Cohen comprehensive Tulsi reviewPhytother Res 2014
Marc Cohen (RMIT University Australia) comprehensive review of Tulsi clinical research consolidating modern evidence base. Authoritative modern reference establishing the integrated framework.
Jamshidi and Cohen systematic reviewEvid Based Complement Alternat Med 2017
Systematic review of human clinical Tulsi trials: support for stress, anxiety, metabolic, and immune applications at modest effect sizes. Modern consolidation of evidence base.
Sampath cognitive function trialJ Altern Complement Med 2015
Indian RCT: 300mg Tulsi extract twice daily for 30 days improved attention and short-term memory in healthy adults versus placebo. Established the modest cognitive function evidence.
Singh Krishna Tulsi diabetes trialInt J Ayurveda Pharma Res 2014
Indian RCT: Krishna Tulsi leaf powder 1g three times daily for 60 days reduced HbA1c, fasting glucose, and lipid profile markers in type 2 diabetes patients. Consolidated the glycemic and metabolic evidence base.
Mohan radiation protection preclinicalCancer Lett 2005
Preclinical evidence for Tulsi extract radioprotective effects in animal models; potential application in cancer radiation therapy adjunct contexts. Established the radioprotection research direction; clinical translation limited.
Cohen Tulsi religious-medical reviewJ Ayurveda Integr Med 2014
Cohen's review specifically on the intersection of religious veneration and medicinal use in Tulsi tradition. Documents the unusual depth of cultural-medical integration that distinguishes Tulsi from other adaptogen evidence bases.